You are viewing the site in preview mode

Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: The landscape of novel antidiabetic drugs in diabetic HFpEF: relevant mechanisms and clinical implications

Fig. 3

The relevant mechanisms of the novel antidiabetic drugs in diabetic HFpEF through mitochondrial dysfunction, autophagy and ferroptosis. Novel antidiabetic drugs mitigated mitochondrial dysfunction and ferroptosis, as well as promoted autophagy by activating Xc−/GSH/GPX4 axis and SIRT3-mediated autophagic pathway, or by inhibiting TGF-β/Smad pathway, ultimately improving diabetic HFpEF

Back to article page